OGN

Organon & Co. (OGN)

About Organon & Co. (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$18.15

Daily low

$17.81

Price at open

$18.01

52 Week High

$23.10

52 Week Low

$10.84

Market cap

4.7B

Dividend yield

6.19%

Volume

Avg. volume

2.3M

P/E ratio

4.66

Organon & Co. News